BioCentury
ARTICLE | Clinical News

Bio-Technology General Corp regulatory update

January 24, 1994 8:00 AM UTC

BTGC also entered into an agreement with CSL Limited (Australia) to market Oxandrin in Australia, New Zealand and the South Pacific. CSL will begin marketing Oxandrin in the first quarter of this year...